UPC Analytics
ENDE
Overview · Filed:

UPC_APP_36985/2025

Methods of Using Sustained Release Aminopyridine Compositions

Procedural & sub-applicationsOther ProceduralParis LDGeneric application
  • 2025-09-17Procedural onlyproceduralGeneric application

    Paris Local Division order (judge-rapporteur Lignières, full panel) in provisional measures proceedings by Merz Therapeutics GmbH and related Merz entities against Viatris Santé concerning EP 2 377 536 (botulinum toxin / SPC FR13C0033). The order addresses Merz's procedural application (R. 9 RoP) to limit or restructure Viatris' 473-page objection, or alternatively to set a page limit for subsequent submissions. No substantive ruling on the provisional measures application.